FDA victory offers hope for better stem cell regulation

The significance of the appeal court's decision in California to rule in favour with the FDA is that it reaffirms the FDA's authority over bogus stem cell treatments... After almost two years, the US Food and Drug Administration (FDA) has won its appeal in a stem cell lawsuit in California brought by the FDA against the California Stem Cell Treatment Center (CSCTC), which was brought to the Court of Appeals for the Ninth Circuit.